Clinical Trial Update: Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous thrombolytic therapy for acute ischemic stroke patients with low NIHSS scores and non-disabling deficits is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Thrombosis, Acute Ischemic Stroke (AIS) | Phase 4 | Status: NOT_YET_RECRUITING